Hypertrophic cardiomyopathy and planned in vitro fertilization. Genetic testing and clinical evaluation.
Hypertrophic cardiomyopathy (HCM) is often transmitted to the offspring of affected individuals. This case report describes the role of genetic screening in a 39-year-old woman with a family history of sudden cardiac death. The patient wished to become pregnant and was seeking medical consultation. In addition to electro- and echocardiograms, genomic DNA was isolated and direct sequencing was employed to screen the patient for some of the most common genes that cause HCM. A pathogenic heterozygous mutation c.700 g > a p.Arg186Gln in TNNI3 was identified, which was not found in 200 normal control chromosomes. Mutation-specific genetic testing was also performed in four family members, and the same mutation was absent. Genetic screening appears cost effective in familiar members with a known mutation, provides important information about the affected individual, and can facilitate the future management of family members and offspring.
The Cardiology Department, The Second Affiliated Hospital of NanChang University, Jiangxi.
J
J
Zhu Hu
J
J
Xiang Li
K
K
Hong
J
J
Xin Hu
P
P
Brugada
X
X
Shu Cheng
D000328:Adult; D024741:Cardiomyopathy, Hypertrophic, Familial / Q000175:diagnosis* / Q000235:genetics*; D005260:Female; D005307:Fertilization in Vitro; D005817:Genetic Counseling; D020022:Genetic Predisposition to Disease / Q000235:genetics* / Q000517:prevention & control; D005820:Genetic Testing; D006801:Humans; D018570:Risk Assessment; D055815:Young Adult